| Could An Aspirin A Day Help Keep Prostate Cancer Away?ROCHESTER, MINN. -- A Mayo Clinic study suggests 
    that regular use of aspirin, ibuprofen and other nonsteroidal 
    anti-inflammatory drugs (NSAIDs) may help protect against prostate cancer, 
    the second leading cause of cancer death among men in the United States.  The study found that men age 60 and older who used NSAIDs daily reduced 
    their risk of prostate cancer by as much as 60 percent. The study also 
    suggested that the beneficial effect may increase with age.  The findings of this study are published in the March issue of Mayo 
    Clinic Proceedings.  The 1,362 Caucasian men in this study were followed for an average of 
    five and one-half years. Of the 569 men who reported using NSAIDs daily, 23 
    developed prostate cancer, compared with 68 of 793 men in the same study who 
    did not use NSAIDs daily and developed the disease.  "These numbers mean the proportion of men who used NSAIDs daily and 
    developed prostate cancer was about one-half that of men who did not use 
    NSAIDs daily -- four percent compared to nine percent," says Rosebud 
    Roberts, M.D., a Mayo Clinic epidemiologist and lead researcher on the 
    study.  "Further, the association between NSAIDs and prostate cancer appears to 
    be stronger in older men," says Dr. Roberts. "The risk of prostate cancer 
    among NSAID users was 12 percent lower in men age 50 to 59 years, 60 percent 
    lower in men 60 to 69 years, and 83 percent lower in men age 70 to 79 years 
    compared to men in those same age groups who did not use NSAIDs daily."  The results may mean good news for men, but Dr. Roberts cautions that 
    more research needs to be done.  "Although our findings provide important information that NSAIDs may 
    protect against prostate cancer, they are not conclusive," says Dr. Roberts.
     "More research needs to be done to show that the results we saw in our 
    study were not unique to our study but can be confirmed in other similar 
    studies," she said. "We also need to determine the duration and dosage use 
    that provides protection against prostate cancer and to better understand 
    the biologic mechanisms underlying the association between NSAIDs and 
    prostate cancer."  Dr. Roberts added that since the study included only Caucasian men in 
    southeastern Minnesota, it’s not known whether the findings apply to men of 
    all races.  "African American men have the highest risk of prostate cancer," said Dr. 
    Roberts. We need to complete additional research to determine if these 
    findings are applicable to them."  Should a man age 50 or older take an aspirin, ibuprofen or another NSAID 
    every day based on the study’s findings?  "Men should discuss the study with their doctors and follow their 
    doctor’s advice, but they should not start taking NSAIDs solely on the basis 
    of our findings," says Dr. Roberts.  "While our findings complement previous studies that NSAIDs help protect 
    against breast and colon cancers, and possibly against prostate cancer, 
    there are also negative side effects of NSAIDs that need to be considered 
    and monitored in people who take NSAIDs on a daily basis," she says.  About 189,000 men in the United States will be diagnosed with prostate 
    cancer this year. About 30,200 men will die of the disease.  This study was part of a larger Mayo Clinic study that monitored lower 
    urinary tract symptoms in 2,115 men from Olmsted County of southeastern 
    Minnesota. The men ranged in age from 40 to79 years at the onset of the 
    study in 1990.  The findings about the association between prostate cancer and NSAIDs are 
    based on information obtained from a subset of 1,362 men in the study who 
    were age 50 years and older in 1990. These men reported using 40 different 
    prescription and over-the-counter NSAIDs at the beginning of the study and 
    during follow-up.  http://www.sciencedaily.com/releases/2002/03/020313075214.htm Second Thoughts on Mercury in FishBy MARIAN BURROSNew York Times 
     AS 
    the Food and Drug Administration overly sensitive to the commercial 
    interests of the tuna industry when it established guidelines on fish 
    consumption and mercury contamination? Documents released this month by a 
    watchdog group are raising that question as well as others about the 
    decision-making that went into the agency's warning to pregnant women about 
    which fish to avoid to reduce the risk of harming their fetuses. The documents, obtained under the Freedom of Information Act by the 
    Environmental Working Group, include 1,000 pages of transcripts and other 
    reports related to meetings and discussions that led to the January 2001 
    advisory that pregnant women not eat fish like mackerel and swordfish. Among 
    them were three meetings the F.D.A. had with the U.S. Tuna Foundation, 
    Chicken of the Sea, Starkist, Bumble Bee and the National Food Processors 
    Association. The industry meetings in themselves were not unusual. However, the 
    Environmental Working Group and at least one member of Congress are 
    questioning whether undue weight was given to the industry's position, while 
    the opinions of others, including consumer focus groups, were discounted. Earlier this month the F.D.A. itself acknowledged a need to revisit its 
    own recommendations. In a rare move, just a year after its list was 
    released, the agency announced a meeting of its Foods Advisory Committee to 
    review mercury in seafood. "We are going back because the Environmental Working Group report had 
    some things in there that went to the process, and we wanted to be sure 
    there isn't any question about that," said Joseph A. Levitt, director of the 
    agency's Center for Food Safety and Applied Nutrition. The F.D.A.'s advisory warned pregnant women not to eat swordfish, king 
    mackerel, shark and tilefish because of high levels of mercury contamination 
    that could cause neurological defects or delays in mental development in 
    their children. Mysteriously absent from the list was one of the most 
    significant sources of mercury in the American diet, tuna. The F.D.A. said at the time it had identified those species of most 
    concern to pregnant women, based on scientific evidence, the fact that 
    Americans don't eat dangerous levels of tuna and a desire not to confuse 
    women. "We feel we have evaluated the science in an appropriate way, and our 
    advisory is right on target," Michael Bolger, director of the division of 
    risk assessment of the Center for Food Safety and Applied Nutrition, said 
    last May. Besides, Mr. Bolger added, if given too much information — like 
    guidelines distinguishing between safe and unsafe fish and those to be eaten 
    infrequently — women would stop eating all fish. He based this opinion, he said, on the responses of three focus groups to 
    statements that included the following: "Tuna steaks can be eaten three 
    times a month. You can eat one and a half six-ounce cans of tuna every week 
    with no problems." In a document released at the time, the F.D.A. reiterated its reasoning: 
    "The major points gleaned from the focus groups were to keep the message 
    simple and direct," the report said, adding that if pregnant women were told 
    to limit consumption, they would interpret it to mean "do not consume." The documents obtained by the Environmental Working Group show, however, 
    that women were far more savvy than that. After being presented with 
    examples of detailed health advisories that included specific advice about 
    tuna, 30 out of 37 comments indicated that the respondents would still eat 
    fish but avoid those with high mercury levels, many specifically mentioning 
    that they would continue to eat tuna but in limited amounts. Only seven 
    individual remarks in the transcripts support the F.D.A. assertion that 
    limiting consumption was equated with not eating any fish. More typical was 
    this response from one participant: "My advice would be not to eat the 
    mackerel, the shark and the swordfish. But I would also put in a note; you 
    should limit your intake of the tuna and then, you know, eat the rest of the 
    fish in moderation." Mr. Levitt asserted: "We have different conclusions on what the focus 
    groups said. When we said limit, they heard avoid." Meanwhile, the F.D.A. held three meetings with industry representatives, 
    the documents show. The industry arguments included a claim that tuna 
    consumption "is not as great as anecdotal observations would indicate" — a 
    position that is at odds with the industry's eagerness to keep canned tuna 
    off the advisory list, as well as with tuna's place as the best-selling 
    fish, accounting for a third of all seafood sales in the United States. 
    Nevertheless, the F.D.A. agreed. The two-page rationale, as they called it, 
    released in February 2001, said that those who do eat canned tuna consume, 
    at most, only about seven ounces a week, or not enough to pose a risk of 
    mercury contamination. Following that reasoning, why advise pregnant women not to eat tilefish 
    or shark, which are consumed seldom, if at all? "We'll never know exactly how much influence industry had in the 
    process," said Jane Houlihan, vice president for research at the 
    Environmental Working Group. "What we do know is that tuna was in the draft 
    advisories and wasn't in the final advisory. The F.D.A. ignored the advice 
    from every other group they called in. And we know the F.D.A.'s public 
    excuse for why they dropped tuna from the advisory is untrue. Their excuse 
    is that people don't eat enough canned tuna, so there is no need for an 
    advisory." Randi Thomas, a spokeswoman for the U.S. Tuna Foundation, the trade 
    association representing the domestic canned tuna industry, acknowledged her 
    association's influence. "I certainly hope we had an impact," she said, 
    "because we showed them the nutritional benefits of tuna." Critics of the advisory say the F.D.A. based its recommendations on 
    outdated research about safe mercury levels in the blood, with the limit 
    eight times higher than was deemed safe by both the National Academy of 
    Sciences and the Environmental Protection Agency. If the F.D.A. followed the 
    National Academy's standard, it would tell pregnant women not to eat any 
    tuna steaks at all, and canned tuna only once a month. Meanwhile, the Centers for Disease Control and Prevention has data 
    showing that 10 to 15 percent of American women of child-bearing age — 
    600,000 — have mercury in their blood at levels higher than the E.P.A.'s 
    safe level, putting their children at risk of harm. Scientists are still assessing the impact of mercury on fetuses. Some 
    studies done in other countries have found that mothers who ate fish with 
    high levels of mercury bore children with scores on intelligence tests 7 to 
    8 points lower on a 100-point scale. Two studies linked neurotoxic effects 
    like delays in mental development to chronic fetal exposure to high levels 
    of mercury from fish. While the F.D.A. reviews its advisory, Congress also may take action. 
    Representative Frank Pallone Jr., a New Jersey Democrat, questioned the 
    agency's motives last week and asked the inspector general of Health and 
    Human Services to investigate. Mr. Pallone has introduced legislation that 
    would require the F.D.A. to test mercury levels in fish, a program abandoned 
    in 1998, and to set a safer threshold level for it in seafood. http://www.nytimes.com/2002/03/13/dining/13WELL.html  Return to Top |